Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer

NCT00897702 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT00897702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00897702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Completed
Start date
January 9, 2007
Completion date
January 23, 2026
Enrollment
269 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer